
    
      STUDY DESIGN

        -  Open-label, prospective, parallel group, intent to treat trial

        -  Experiment duration: 5 days

        -  2 visits (days 1, and 5)

        -  Reduction of symptoms

        -  Adverse events evaluation
    
  